370 related articles for article (PubMed ID: 14598943)
1. Postoperative chemotherapy with cisplatin and 5-fluorouracil in cancer of the oral cavity and the oropharynx--long-term results.
Kovács AF; Ghahremani MT; Stefenelli U; Bitter K
J Chemother; 2003 Oct; 15(5):495-502. PubMed ID: 14598943
[TBL] [Abstract][Full Text] [Related]
2. [The role of a surgical method in combined and complex treatment of patients with squamous cell oral and oropharyngeal cancer].
Vikhlianov IV; Shoĭket IaN; Lazarev AF
Khirurgiia (Mosk); 2007; (1):55-8. PubMed ID: 17426691
[TBL] [Abstract][Full Text] [Related]
3. Combined modality treatment of oral and oropharyngeal cancer including neoadjuvant intraarterial cisplatin and radical surgery followed by concurrent radiation and chemotherapy with weekly docetaxel - three year results of a pilot study.
Kovács AF; Schiemann M; Turowski B
J Craniomaxillofac Surg; 2002 Apr; 30(2):112-20. PubMed ID: 12069515
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant chemotherapy in early-stage and locally advanced small bulk squamous cell carcinoma of the oral cavity and oropharynx.
Tichler T; Ramon Y; Rath P; Hendler S; Brenner HJ
Isr J Med Sci; 1988; 24(9-10):539-44. PubMed ID: 2462551
[TBL] [Abstract][Full Text] [Related]
5. [Preliminary results of a prospective randomized study of primary chemotherapy in carcinoma of the oral cavity and pharynx].
Volling P; Schröder M
HNO; 1995 Feb; 43(2):58-64. PubMed ID: 7713766
[TBL] [Abstract][Full Text] [Related]
6. A two-arm multicenter phase II trial of one cycle chemoselection split-dose docetaxel, cisplatin and 5-fluorouracil (TPF) induction chemotherapy before two cycles of split TPF followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer (TISOC-1).
Inhestern J; Schmalenberg H; Dietz A; Rotter N; Maschmeyer G; Jungehülsing M; Grosse-Thie C; Kuhnt T; Görner M; Sudhoff H; Wittekindt C; Guntinas-Lichius O
Ann Oncol; 2017 Aug; 28(8):1917-1922. PubMed ID: 28498880
[TBL] [Abstract][Full Text] [Related]
7. Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced oropharyngeal cancer.
Mantz CA; Vokes EE; Stenson K; Kies MS; Mittal B; Witt ME; List MA; Weichselbaum RR; Haraf DJ
Cancer J; 2001; 7(2):140-8. PubMed ID: 11324767
[TBL] [Abstract][Full Text] [Related]
8. Primary chemotherapy in resectable oral cavity squamous cell cancer: a randomized controlled trial.
Licitra L; Grandi C; Guzzo M; Mariani L; Lo Vullo S; Valvo F; Quattrone P; Valagussa P; Bonadonna G; Molinari R; Cantù G
J Clin Oncol; 2003 Jan; 21(2):327-33. PubMed ID: 12525526
[TBL] [Abstract][Full Text] [Related]
9. Long-term survival in locally advanced oral cavity cancer: an analysis of patients treated with neoadjuvant cisplatin-based chemotherapy followed by surgery.
Ruggeri EM; Carlini P; Pollera CF; De Marco S; Ruscito P; Pinnarò P; Nardi M; Giannarelli D; Cognetti F
Head Neck; 2005 Jun; 27(6):452-8. PubMed ID: 15880411
[TBL] [Abstract][Full Text] [Related]
10. Phase II study of induction and adjuvant chemotherapy for squamous cell carcinoma of the head and neck. A long-term analysis for the Illinois Cancer Center.
Athanasiadis I; Taylor S; Vokes EE; Pelzer HJ; Rademaker A; Mittal BB; Ganzenko N; Blough R; Lester EP; Kies MS
Cancer; 1997 Feb; 79(3):588-94. PubMed ID: 9028372
[TBL] [Abstract][Full Text] [Related]
11. Relevance of positive margins in case of adjuvant therapy of oral cancer.
Kovács AF
Int J Oral Maxillofac Surg; 2004 Jul; 33(5):447-53. PubMed ID: 15183407
[TBL] [Abstract][Full Text] [Related]
12. Biological markers and prognosis in recurrent oral cancer after salvage surgery.
Agra IM; Carvalho AL; Pinto CA; Martins EP; Filho JG; Soares FA; Kowalski LP
Arch Otolaryngol Head Neck Surg; 2008 Jul; 134(7):743-9. PubMed ID: 18645125
[TBL] [Abstract][Full Text] [Related]
13. Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy.
Furness S; Glenny AM; Worthington HV; Pavitt S; Oliver R; Clarkson JE; Macluskey M; Chan KK; Conway DI;
Cochrane Database Syst Rev; 2010 Sep; (9):CD006386. PubMed ID: 20824847
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant chemotherapy with 5-fluorouracil and cisplatin in lymph node-positive thoracic esophageal squamous cell carcinoma.
Lee J; Lee KE; Im YH; Kang WK; Park K; Kim K; Shim YM
Ann Thorac Surg; 2005 Oct; 80(4):1170-5. PubMed ID: 16181835
[TBL] [Abstract][Full Text] [Related]
15. Multidisciplinary approach in advanced cancer of the oral cavity: outcome with neoadjuvant chemotherapy according to intention-to-treat local therapy. A phase II study.
Grau JJ; Domingo J; Blanch JL; Verger E; Castro V; Nadal A; Alós L; Estapé J
Oncology; 2002; 63(4):338-45. PubMed ID: 12417788
[TBL] [Abstract][Full Text] [Related]
16. Retrospective analysis on prognostic impact of adjuvant chemotherapy in the patients with advanced and resectable oral squamous cell carcinoma.
Kurita H; Koike T; Miyazawa H; Uehara S; Kobayashi H; Kurashina K
Gan To Kagaku Ryoho; 2006 Jul; 33(7):915-21. PubMed ID: 16835480
[TBL] [Abstract][Full Text] [Related]
17. [Local chemotherapy for squamous cell cancer of the oral cavity and oropharynx].
Rohde S; Kovács AF; Zanella FE; Berkefeld J; Turowski B
Radiologe; 2005 Sep; 45(9):843-50. PubMed ID: 16021409
[TBL] [Abstract][Full Text] [Related]
18. TP53 mutations and pathologic complete response to neoadjuvant cisplatin and fluorouracil chemotherapy in resected oral cavity squamous cell carcinoma.
Perrone F; Bossi P; Cortelazzi B; Locati L; Quattrone P; Pierotti MA; Pilotti S; Licitra L
J Clin Oncol; 2010 Feb; 28(5):761-6. PubMed ID: 20048189
[TBL] [Abstract][Full Text] [Related]
19. Induction chemotherapy in head and neck cancer: results of a phase III trial.
Mazeron JJ; Martin M; Brun B; Grimard L; Lelièvre G; Vergnes L; Haddad E; Feuilhade F; Piedbois P; Strunski W
Head Neck; 1992; 14(2):85-91. PubMed ID: 1376306
[TBL] [Abstract][Full Text] [Related]
20. Induction chemotherapy is associated with an increase in the incidence of locoregional recurrence in patients with carcinoma of the oral cavity: results from a single institution.
Okura M; Hiranuma T; Adachi T; Ogura T; Aikawa T; Yoshioka H; Hayashido Y; Kogo M; Matsuya T
Cancer; 1998 Mar; 82(5):804-15. PubMed ID: 9486567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
